Aldosterone receptor antagonists
https://themeditary.com/breastfeeding/finerenone-use-while-breastfeeding-11737.html

Finerenone use while Breastfeeding

Drug Detail:Finerenone (Finerenone [ fin-er-e-none ])

Drug Class: Aldosterone receptor antagonists

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Finerenone Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of finerenone during breastfeeding. Finerenone is 92% bound to plasma proteins, so amounts in milk are likely to be low. However, the manufacturer recommends avoiding breastfeeding during treatment and for 1 day after treatment.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Eplerenone, Spironlactone

Substance Identification

Substance Name

Finerenone

CAS Registry Number

1050477-31-0

Drug Class

Breast Feeding

Lactation

Mineralocorticoid Receptor Antagonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Share this Article
Latest News
Related Drugs